MEDICINE, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING UROGENITAL DISEASES OF THE HUMAN BODY CAUSED BY MICROORGANISMS OF THE UREAPLASMA UREALYTICUM TYPE Russian patent published in 2019 - IPC A61K36/15 A61K31/00 A61P13/00 

FIELD: medicine; pharmaceuticals.

SUBSTANCE: invention relates to the pharmaceutical industry, in particular to an agent for the treatment of urogenital diseases of the human body caused by microorganisms of the Ureaplasma urealyticum species. Drug for the treatment of urogenital diseases of the human body caused by microorganisms of the species Ureaplasma urealyticum, which is a coniferous chlorophyll-carotene complex, obtained from pine needles based on Pinus Sylvestris and Picea abies (L.) Karst, taken at a ratio of 55:45, coniferous chlorophyll-carotene complex contains water in the amount of 38–42 wt%, the amount of erosive substances 55–61 wt%, the amount of chlorophyll derivatives 0.6–1.2 wt%, moreover, the amount of extractive substances contains: 42–47 wt% of free acids, including pinifilic acid in the amount of 16.5–21.4 wt% of the sum of free acids, 53–58 wt% of neutral components, including in wt% of the sum of neutral components: isoabienol in the amount of 19.3–24.4; the amount of carotenoids selected from lutein, zeaxanthin, β-carotene, 0.3–0.5; waxes 1.7–3.1; essential oils 0.6–0.9. Pharmaceutical composition for the treatment of urogenital diseases of the human body caused by microorganisms of the species Ureaplasma urealyticum. Use of coniferous chlorophyll-carotene complex for the treatment of urogenital diseases of the human body caused by microorganisms of the species Ureaplasma urealyticum. Method for the treatment of urogenital diseases of the human body caused by microorganisms of the species Ureaplasma urealyticum.

EFFECT: above remedy is effective for the treatment of urogenital diseases of the human body caused by microorganisms of the species Ureaplasma urealyticum.

5 cl, 6 tbl, 8 ex